Dipexium Pharmaceuticals, Inc.'s Chief Accounting Officer was just granted 35,000 options

Robert G. Shawah, Dipexium Pharmaceuticals, Inc.'s Chief Accounting Officer, just received 35,000 options from the company. The strike price of the options received was $11.35, and these expire on January 05, 2025. Shawah now owns at least 120 options on the company.

Some additional info was provided as follows:

Options vest as follows: 50% on the date of grant and the remaining 50% vests in equal installments over a 24 month period, subject to accelerated vesting on a change of control.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Dipexium Pharmaceuticals: Plx Pharma Hires Key Commercial Executives In Preparation For Future Launch Of Aspertec - Sept. 19, 2017

Auto Refresh

Feedback